Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy

BACKGROUND: Nausea and vomiting of pregnancy (NVP) affects up to 80% of expecting mothers. In April 2013 the FDA approved the delayed-release combination of doxylamine succinate and pyridoxine hydrochloride (Diclegis®) for NVP, based in part, on the results of a phase III randomized trial demonstrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Koren, Gideon, Clark, Shannon, Hankins, Gary D. V., Caritis, Steve N., Umans, Jason G., Miodovnik, Menachem, Mattison, Donald R., Matok, Ilan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122025/
https://www.ncbi.nlm.nih.gov/pubmed/27881103
http://dx.doi.org/10.1186/s12884-016-1172-9

Ejemplares similares

Ejemplares similares